Global Blood Glucose Device

Blood Glucose Device Comprehensive Study by Type (Continuous Glucose Monitoring Device (CGMs), Self-Monitoring Blood Glucose System (SMBGs)), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others), By Compatibility (Diasend, Diabass, SiDiary, Others), By Measurement Unit (Mmol/L, Mg/dL) Players and Region - Global Market Outlook to 2026

Blood Glucose Device Market by XX Submarkets | Forecast Years 2021-2026  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Blood Glucose Device Market Scope
Blood Glucose Device is a medical device used to estimate the concentration of glucose in the blood. It could also be a strip of glucose paper dipped in a substance and measured in relation to a glucose chart. A small drop of blood is obtained by pricking the skin with a lancet and placed on a disposable test strip, which is read by the metre and used to calculate the blood glucose level. The level is then displayed in mg/dL or mmol/L units by the metre. People with type 1 diabetes, type 2 diabetes, latent autoimmune diabetes in adults (LADA), or gestational diabetes. A glucometer is used to test blood glucose levels on a regular basis as part of their treatment plan.

The Blood Glucose Device market study is segmented by Type (Continuous Glucose Monitoring Device (CGMs) and Self-Monitoring Blood Glucose System (SMBGs)), by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Others) and major geographies with country level break-up.

The demand for Blood Glucose Device is increasing due to growing diabetes population with each passing day. The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market soon. Players are expected to concentrate on the creation of novel compounds, which would likely boost the worldwide market's growth throughout the forecast period. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Blood Glucose Device market throughout the predicted period.

Sanofi (France), Dexcom (United States), Medtronic (Ireland), Abbott Laboratories (United States), Senseonics Holdings (United States), Roche Holding AG (Switzerland), LifeScan, Inc. (Platinum Equity) (United States), Pulsatom Healthcare (India), Beurer (Germany) and B. Braun (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are One Drop (United States), PHC Holdings (Japan) and DarioHealth (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Blood Glucose Device market by Type, Application and Region.

On the basis of geography, the market of Blood Glucose Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In September 2019 Sanofi announced the partnership with Abbott Laboratories. The two companies will take a unique strategy to work with clients by creating apps that combine the revolutionary FreeStyle Libre technology with insulin dosing data for future smart pens, insulin titration apps, and cloud software.


Market Trend
  • Rapid Development in Use of Smart Devices and Smart Phones in Blood Glucose Device

Market Drivers
  • Rising Diabetic Patient Population
  • Growing Adoption of Continuous Glucose Monitoring (CGM) Systems

Opportunities
  • Increase in Awareness of Blood Glucose Device

Restraints
  • The Side-Effects of Using Device Kidney Disease, Heart Disease, Eye Involvement and Nerve Involvement

Challenges
  • Lack of Accuracy for Each Single Data Point in CGMs
  • Blood Glucose Device and strips are Very Expensive


Key Target Audience
Venture and Capitalist, New entrants/investors, Hospitals, Clinics, Residential and End-use industries

Report Objectives / Segmentation Covered

By Type
  • Continuous Glucose Monitoring Device (CGMs)
  • Self-Monitoring Blood Glucose System (SMBGs)
By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Others
By By Compatibility
  • Diasend
  • Diabass
  • SiDiary
  • Others

By By Measurement Unit
  • Mmol/L
  • Mg/dL

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Diabetic Patient Population
      • 3.2.2. Growing Adoption of Continuous Glucose Monitoring (CGM) Systems
    • 3.3. Market Challenges
      • 3.3.1. Lack of Accuracy for Each Single Data Point in CGMs
      • 3.3.2. Blood Glucose Device and strips are Very Expensive
    • 3.4. Market Trends
      • 3.4.1. Rapid Development in Use of Smart Devices and Smart Phones in Blood Glucose Device
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Glucose Device, by Type, Application, By Compatibility, By Measurement Unit and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blood Glucose Device (Value)
      • 5.2.1. Global Blood Glucose Device by: Type (Value)
        • 5.2.1.1. Continuous Glucose Monitoring Device (CGMs)
        • 5.2.1.2. Self-Monitoring Blood Glucose System (SMBGs)
      • 5.2.2. Global Blood Glucose Device by: Application (Value)
        • 5.2.2.1. Type 1 Diabetes
        • 5.2.2.2. Type 2 Diabetes
        • 5.2.2.3. Gestational Diabetes
        • 5.2.2.4. Others
      • 5.2.3. Global Blood Glucose Device by: By Compatibility (Value)
        • 5.2.3.1. Diasend
        • 5.2.3.2. Diabass
        • 5.2.3.3. SiDiary
        • 5.2.3.4. Others
      • 5.2.4. Global Blood Glucose Device by: By Measurement Unit (Value)
        • 5.2.4.1. Mmol/L
        • 5.2.4.2. Mg/dL
      • 5.2.5. Global Blood Glucose Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Blood Glucose Device (Price)
      • 5.3.1. Global Blood Glucose Device by: Type (Price)
  • 6. Blood Glucose Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sanofi (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Dexcom (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Senseonics Holdings (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Roche Holding AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LifeScan, Inc. (Platinum Equity) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Pulsatom Healthcare (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Beurer (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. B. Braun (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Glucose Device Sale, by Type, Application, By Compatibility, By Measurement Unit and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blood Glucose Device (Value)
      • 7.2.1. Global Blood Glucose Device by: Type (Value)
        • 7.2.1.1. Continuous Glucose Monitoring Device (CGMs)
        • 7.2.1.2. Self-Monitoring Blood Glucose System (SMBGs)
      • 7.2.2. Global Blood Glucose Device by: Application (Value)
        • 7.2.2.1. Type 1 Diabetes
        • 7.2.2.2. Type 2 Diabetes
        • 7.2.2.3. Gestational Diabetes
        • 7.2.2.4. Others
      • 7.2.3. Global Blood Glucose Device by: By Compatibility (Value)
        • 7.2.3.1. Diasend
        • 7.2.3.2. Diabass
        • 7.2.3.3. SiDiary
        • 7.2.3.4. Others
      • 7.2.4. Global Blood Glucose Device by: By Measurement Unit (Value)
        • 7.2.4.1. Mmol/L
        • 7.2.4.2. Mg/dL
      • 7.2.5. Global Blood Glucose Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Blood Glucose Device (Price)
      • 7.3.1. Global Blood Glucose Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Glucose Device: by Type(USD Million)
  • Table 2. Blood Glucose Device Continuous Glucose Monitoring Device (CGMs) , by Region USD Million (2015-2020)
  • Table 3. Blood Glucose Device Self-Monitoring Blood Glucose System (SMBGs) , by Region USD Million (2015-2020)
  • Table 4. Blood Glucose Device: by Application(USD Million)
  • Table 5. Blood Glucose Device Type 1 Diabetes , by Region USD Million (2015-2020)
  • Table 6. Blood Glucose Device Type 2 Diabetes , by Region USD Million (2015-2020)
  • Table 7. Blood Glucose Device Gestational Diabetes , by Region USD Million (2015-2020)
  • Table 8. Blood Glucose Device Others , by Region USD Million (2015-2020)
  • Table 9. Blood Glucose Device: by By Compatibility(USD Million)
  • Table 10. Blood Glucose Device Diasend , by Region USD Million (2015-2020)
  • Table 11. Blood Glucose Device Diabass , by Region USD Million (2015-2020)
  • Table 12. Blood Glucose Device SiDiary , by Region USD Million (2015-2020)
  • Table 13. Blood Glucose Device Others , by Region USD Million (2015-2020)
  • Table 14. Blood Glucose Device: by By Measurement Unit(USD Million)
  • Table 15. Blood Glucose Device Mmol/L , by Region USD Million (2015-2020)
  • Table 16. Blood Glucose Device Mg/dL , by Region USD Million (2015-2020)
  • Table 17. South America Blood Glucose Device, by Country USD Million (2015-2020)
  • Table 18. South America Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 19. South America Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 20. South America Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 21. South America Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 22. Brazil Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 23. Brazil Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 24. Brazil Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 25. Brazil Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 26. Argentina Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 27. Argentina Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 28. Argentina Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 29. Argentina Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 30. Rest of South America Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 33. Rest of South America Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 34. Asia Pacific Blood Glucose Device, by Country USD Million (2015-2020)
  • Table 35. Asia Pacific Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 36. Asia Pacific Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 37. Asia Pacific Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 38. Asia Pacific Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 39. China Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 40. China Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 41. China Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 42. China Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 43. Japan Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 44. Japan Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 45. Japan Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 46. Japan Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 47. India Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 48. India Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 49. India Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 50. India Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 51. South Korea Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 52. South Korea Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 53. South Korea Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 54. South Korea Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 55. Taiwan Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 56. Taiwan Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 57. Taiwan Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 58. Taiwan Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 59. Australia Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 60. Australia Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 61. Australia Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 62. Australia Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 67. Europe Blood Glucose Device, by Country USD Million (2015-2020)
  • Table 68. Europe Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 69. Europe Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 70. Europe Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 71. Europe Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 72. Germany Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 73. Germany Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 74. Germany Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 75. Germany Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 76. France Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 77. France Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 78. France Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 79. France Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 80. Italy Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 81. Italy Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 82. Italy Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 83. Italy Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 84. United Kingdom Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 85. United Kingdom Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 86. United Kingdom Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 87. United Kingdom Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 88. Netherlands Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 89. Netherlands Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 90. Netherlands Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 91. Netherlands Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 92. Rest of Europe Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 93. Rest of Europe Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 94. Rest of Europe Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 95. Rest of Europe Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 96. MEA Blood Glucose Device, by Country USD Million (2015-2020)
  • Table 97. MEA Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 98. MEA Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 99. MEA Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 100. MEA Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 101. Middle East Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 102. Middle East Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 103. Middle East Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 104. Middle East Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 105. Africa Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 106. Africa Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 107. Africa Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 108. Africa Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 109. North America Blood Glucose Device, by Country USD Million (2015-2020)
  • Table 110. North America Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 111. North America Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 112. North America Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 113. North America Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 114. United States Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 115. United States Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 116. United States Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 117. United States Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 118. Canada Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 119. Canada Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 120. Canada Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 121. Canada Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 122. Mexico Blood Glucose Device, by Type USD Million (2015-2020)
  • Table 123. Mexico Blood Glucose Device, by Application USD Million (2015-2020)
  • Table 124. Mexico Blood Glucose Device, by By Compatibility USD Million (2015-2020)
  • Table 125. Mexico Blood Glucose Device, by By Measurement Unit USD Million (2015-2020)
  • Table 126. Blood Glucose Device: by Type(USD/Units)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Blood Glucose Device: by Type(USD Million)
  • Table 138. Blood Glucose Device Continuous Glucose Monitoring Device (CGMs) , by Region USD Million (2021-2026)
  • Table 139. Blood Glucose Device Self-Monitoring Blood Glucose System (SMBGs) , by Region USD Million (2021-2026)
  • Table 140. Blood Glucose Device: by Application(USD Million)
  • Table 141. Blood Glucose Device Type 1 Diabetes , by Region USD Million (2021-2026)
  • Table 142. Blood Glucose Device Type 2 Diabetes , by Region USD Million (2021-2026)
  • Table 143. Blood Glucose Device Gestational Diabetes , by Region USD Million (2021-2026)
  • Table 144. Blood Glucose Device Others , by Region USD Million (2021-2026)
  • Table 145. Blood Glucose Device: by By Compatibility(USD Million)
  • Table 146. Blood Glucose Device Diasend , by Region USD Million (2021-2026)
  • Table 147. Blood Glucose Device Diabass , by Region USD Million (2021-2026)
  • Table 148. Blood Glucose Device SiDiary , by Region USD Million (2021-2026)
  • Table 149. Blood Glucose Device Others , by Region USD Million (2021-2026)
  • Table 150. Blood Glucose Device: by By Measurement Unit(USD Million)
  • Table 151. Blood Glucose Device Mmol/L , by Region USD Million (2021-2026)
  • Table 152. Blood Glucose Device Mg/dL , by Region USD Million (2021-2026)
  • Table 153. South America Blood Glucose Device, by Country USD Million (2021-2026)
  • Table 154. South America Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 155. South America Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 156. South America Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 157. South America Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 158. Brazil Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 159. Brazil Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 160. Brazil Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 161. Brazil Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 162. Argentina Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 163. Argentina Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 164. Argentina Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 165. Argentina Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 166. Rest of South America Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 167. Rest of South America Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 168. Rest of South America Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 169. Rest of South America Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 170. Asia Pacific Blood Glucose Device, by Country USD Million (2021-2026)
  • Table 171. Asia Pacific Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 172. Asia Pacific Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 173. Asia Pacific Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 174. Asia Pacific Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 175. China Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 176. China Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 177. China Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 178. China Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 179. Japan Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 180. Japan Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 181. Japan Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 182. Japan Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 183. India Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 184. India Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 185. India Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 186. India Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 187. South Korea Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 188. South Korea Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 189. South Korea Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 190. South Korea Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 191. Taiwan Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 192. Taiwan Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 193. Taiwan Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 194. Taiwan Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 195. Australia Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 196. Australia Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 197. Australia Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 198. Australia Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 199. Rest of Asia-Pacific Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 203. Europe Blood Glucose Device, by Country USD Million (2021-2026)
  • Table 204. Europe Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 205. Europe Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 206. Europe Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 207. Europe Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 208. Germany Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 209. Germany Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 210. Germany Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 211. Germany Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 212. France Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 213. France Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 214. France Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 215. France Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 216. Italy Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 217. Italy Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 218. Italy Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 219. Italy Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 220. United Kingdom Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 221. United Kingdom Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 222. United Kingdom Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 223. United Kingdom Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 224. Netherlands Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 225. Netherlands Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 226. Netherlands Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 227. Netherlands Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 228. Rest of Europe Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 229. Rest of Europe Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 230. Rest of Europe Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 231. Rest of Europe Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 232. MEA Blood Glucose Device, by Country USD Million (2021-2026)
  • Table 233. MEA Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 234. MEA Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 235. MEA Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 236. MEA Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 237. Middle East Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 238. Middle East Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 239. Middle East Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 240. Middle East Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 241. Africa Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 242. Africa Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 243. Africa Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 244. Africa Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 245. North America Blood Glucose Device, by Country USD Million (2021-2026)
  • Table 246. North America Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 247. North America Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 248. North America Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 249. North America Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 250. United States Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 251. United States Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 252. United States Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 253. United States Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 254. Canada Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 255. Canada Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 256. Canada Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 257. Canada Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 258. Mexico Blood Glucose Device, by Type USD Million (2021-2026)
  • Table 259. Mexico Blood Glucose Device, by Application USD Million (2021-2026)
  • Table 260. Mexico Blood Glucose Device, by By Compatibility USD Million (2021-2026)
  • Table 261. Mexico Blood Glucose Device, by By Measurement Unit USD Million (2021-2026)
  • Table 262. Blood Glucose Device: by Type(USD/Units)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Glucose Device: by Type USD Million (2015-2020)
  • Figure 5. Global Blood Glucose Device: by Application USD Million (2015-2020)
  • Figure 6. Global Blood Glucose Device: by By Compatibility USD Million (2015-2020)
  • Figure 7. Global Blood Glucose Device: by By Measurement Unit USD Million (2015-2020)
  • Figure 8. South America Blood Glucose Device Share (%), by Country
  • Figure 9. Asia Pacific Blood Glucose Device Share (%), by Country
  • Figure 10. Europe Blood Glucose Device Share (%), by Country
  • Figure 11. MEA Blood Glucose Device Share (%), by Country
  • Figure 12. North America Blood Glucose Device Share (%), by Country
  • Figure 13. Global Blood Glucose Device: by Type USD/Units (2015-2020)
  • Figure 14. Global Blood Glucose Device share by Players 2020 (%)
  • Figure 15. Global Blood Glucose Device share by Players (Top 3) 2020(%)
  • Figure 16. Global Blood Glucose Device share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 19. Sanofi (France) Revenue: by Geography 2020
  • Figure 20. Dexcom (United States) Revenue, Net Income and Gross profit
  • Figure 21. Dexcom (United States) Revenue: by Geography 2020
  • Figure 22. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 24. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 26. Senseonics Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 27. Senseonics Holdings (United States) Revenue: by Geography 2020
  • Figure 28. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Roche Holding AG (Switzerland) Revenue: by Geography 2020
  • Figure 30. LifeScan, Inc. (Platinum Equity) (United States) Revenue, Net Income and Gross profit
  • Figure 31. LifeScan, Inc. (Platinum Equity) (United States) Revenue: by Geography 2020
  • Figure 32. Pulsatom Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 33. Pulsatom Healthcare (India) Revenue: by Geography 2020
  • Figure 34. Beurer (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Beurer (Germany) Revenue: by Geography 2020
  • Figure 36. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 37. B. Braun (Germany) Revenue: by Geography 2020
  • Figure 38. Global Blood Glucose Device: by Type USD Million (2021-2026)
  • Figure 39. Global Blood Glucose Device: by Application USD Million (2021-2026)
  • Figure 40. Global Blood Glucose Device: by By Compatibility USD Million (2021-2026)
  • Figure 41. Global Blood Glucose Device: by By Measurement Unit USD Million (2021-2026)
  • Figure 42. South America Blood Glucose Device Share (%), by Country
  • Figure 43. Asia Pacific Blood Glucose Device Share (%), by Country
  • Figure 44. Europe Blood Glucose Device Share (%), by Country
  • Figure 45. MEA Blood Glucose Device Share (%), by Country
  • Figure 46. North America Blood Glucose Device Share (%), by Country
  • Figure 47. Global Blood Glucose Device: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Sanofi (France)
  • Dexcom (United States)
  • Medtronic (Ireland)
  • Abbott Laboratories (United States)
  • Senseonics Holdings (United States)
  • Roche Holding AG (Switzerland)
  • LifeScan, Inc. (Platinum Equity) (United States)
  • Pulsatom Healthcare (India)
  • Beurer (Germany)
  • B. Braun (Germany)
Additional players considered in the study are as follows:
One Drop (United States) , PHC Holdings (Japan) , DarioHealth (United States)
Select User Access Type

Key Highlights of Report


Dec 2021 242 Pages 53 Tables Base Year: 2020 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Glucose Device Quantitative research analysis
Global Blood Glucose Device Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Know More About Global Blood Glucose Device Report?

Have a Query? Click Here

Other Related Reports

Anesthesia Devices Comprehensive Study by Type (Anesthesia Delivery Machines, Anesthesia Delivery Machines, Disposables & Accessories, Anesthesia Monitors, Anesthesia Information Management Systems),...
$ 3750
Arterial Stents Comprehensive Study by Type (Coronary Stents, Peripheral Stents), Application (Coronary Artery, Carotid Artery, Carotid Artery, Femoral & Popliteal Artery), End Users (Hospitals, Diag...
$ 3800
Ultrasonic Tip Comprehensive Study by Type (Flexible, Normal), Application (Clinics, Hospitals, Others), Sales Channel (Online, Offline) Players and Region - Global Market Outlook to 2026
$ 3500
ICU Beds Comprehensive Study by Type (Electric Beds, Semi-Electric Beds, Manual Beds), Application (Traditional ICU, Pediatric ICU, Others), End Use (Neonatal Intensive Care Unit, Pediatric Intensive...
$ 3450
Interbody Fusion Cage Comprehensive Study by Type (Lumbar, Cervical, Thoraco-lumbar, Thoracic), Surgery Type (Anterior Surgery, Transforaminal Surgery, Posterior Surgery, Lateral Surgery), End User (...
$ 3350
Drug-Eluting Stent Comprehensive Study by Type (Cobalt-chromium alloy, Magnesium alloy, Tyrosine polycarbonate, Nitinol, Platinum chromium alloy, Stainless steel, Others), Application (Coronary Heart...
$ 3750